Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harshali K Patel

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacy Practice|October 25, 2013
An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claimsSatabdi Chatterjee, Harshali K Patel, Sujit S Sansgiry
Pharmacy (Basel, Switzerland)|October 17, 2017
Role of Information Anxiety and Information Load on Processing of Prescription Drug Information LeafletsShweta S Bapat, Harshali K Patel, Sujit S Sansgiry
Therapeutic Innovation & Regulatory Science|May 2, 2018
Development of Prescription Drug Information Leaflets: Impact of Cognitive Effort and Patient Involvement on Prescription Medication Information ProcessingHarshali K Patel, Shweta S Bapat, Archita H Bhansali, et al.
Risk Management and Healthcare Policy|May 27, 2017
Economic burden of hospitalizations of Medicare beneficiaries with heart failureMeredith Kilgore, Harshali K Patel, Adrian Kielhorn, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Expanding Consumer Medication Access: The Time Is NowSally A Huston, Suzan Kucukarslan, Harshali K Patel, et al.
Pharmacotherapy|February 4, 2016
Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical CenterAdam P Bress, Jordan B King, Diana Brixner, et al.
Current Medical Research and Opinion|October 14, 2016
Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction ProgramAnuraag R Kansal, Stanimira Krotneva, Ali Tafazzoli, et al.
Journal of Managed Care & Specialty Pharmacy|September 1, 2016
Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United StatesJeffrey S Borer, Anuraag R Kansal, Emily D Dorman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 1, 2018
Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fractionNasrien E Ibrahim, Hanna K Gaggin, Alexander Turchin, et al.
The American Journal of Cardiology|January 26, 2016
Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and CostsAdam D DeVore, Phillip J Schulte, Robert J Mentz, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacy Practice|October 25, 2013
An analysis of the warning letters issued by the FDA to pharmaceutical manufacturers regarding misleading health outcomes claimsSatabdi Chatterjee, Harshali K Patel, Sujit S Sansgiry
Pharmacy (Basel, Switzerland)|October 17, 2017
Role of Information Anxiety and Information Load on Processing of Prescription Drug Information LeafletsShweta S Bapat, Harshali K Patel, Sujit S Sansgiry
Therapeutic Innovation & Regulatory Science|May 2, 2018
Development of Prescription Drug Information Leaflets: Impact of Cognitive Effort and Patient Involvement on Prescription Medication Information ProcessingHarshali K Patel, Shweta S Bapat, Archita H Bhansali, et al.
Risk Management and Healthcare Policy|May 27, 2017
Economic burden of hospitalizations of Medicare beneficiaries with heart failureMeredith Kilgore, Harshali K Patel, Adrian Kielhorn, et al.
Therapeutic Innovation & Regulatory Science|September 20, 2018
Expanding Consumer Medication Access: The Time Is NowSally A Huston, Suzan Kucukarslan, Harshali K Patel, et al.
Pharmacotherapy|February 4, 2016
Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical CenterAdam P Bress, Jordan B King, Diana Brixner, et al.
Current Medical Research and Opinion|October 14, 2016
Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction ProgramAnuraag R Kansal, Stanimira Krotneva, Ali Tafazzoli, et al.
Journal of Managed Care & Specialty Pharmacy|September 1, 2016
Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United StatesJeffrey S Borer, Anuraag R Kansal, Emily D Dorman, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|March 1, 2018
Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fractionNasrien E Ibrahim, Hanna K Gaggin, Alexander Turchin, et al.
The American Journal of Cardiology|January 26, 2016
Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and CostsAdam D DeVore, Phillip J Schulte, Robert J Mentz, et al.
Pageof 1